Table 2 |
|||||
|
Patient parameters |
|||||
|
Disease Status |
Control |
IBD |
Psoriasis |
Rheumatoid arthritis |
|
|
|
|||||
|
n |
18 |
13 |
15 |
12 |
|
|
|
|||||
|
Sex (male/female) |
8/10 |
4/9 |
5/10 |
2/10 |
|
|
|
|||||
|
Age (years) |
40.07 ± 21.3 |
27.92 ± 8.49 |
30.53 ± 9.3 |
45.83 ± 18.24 |
|
|
|
|||||
|
Clinical subtype |
NA |
CD/UC 8/4 |
Arthritis positive/negative 4/11 |
Bone erosion positive/negative 4/8 |
|
|
|
|||||
|
CDAI |
UCDAI |
PASI |
DAS28 |
||
|
|
|||||
|
Clinical severity |
NA |
270.4 ± 67.18 |
8 ± 1.2 |
27.47 ± 9.62 |
6.12 ± 1.05 |
|
|
|||||
|
124-365 |
6-9 |
15-48 |
4.07-7.56 |
||
|
|
|||||
|
Definition of abbreviations: IBD = Inflammatory bowel disease, CD = Crohn's Disease, CDAI = Crohn's Disease Activity Index, UC = Ulcerative colitis, UC DAI = Ulcerative Colitis Disease Activity Index, PASI = Psoriasis Area Severity Index, DAS28 = Disease Activity Score 28, NA = non available. Data are presented as mean ± SD; also range in Clinical Severity. |
|||||
|
Mesko et al. BMC Medical Genomics 2010 3:15 doi:10.1186/1755-8794-3-15 |
|||||
